The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Cyclin D1 in Breast Cancer Pathogenesis
Abstract
Taking a perspective on available evidence that emphasizes relevance to human disease, cyclin D1 is solidly established as an oncogene with an important pathogenetic role in breast cancer and other human tumors. However, the precise cellular mechanisms through which aberrant cyclin D1 expression drives human neoplasia are less well established. Indeed, emerging evidence suggests that cyclin D1 might act, predominantly or at least in part, through pathways that do not involve its widely accepted function as a cell cycle regulator. Although therapeutic exploitation of the role of cyclin D1 as a molecular driver of breast cancer carries great promise, it is also suggested that direct targeting of the cyclin D1 gene or gene products may prove more successful than approaches that rely on arguably incomplete knowledge of the oncogenic mechanisms of cyclin D1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Addiction to Oncogenes--the Achilles Heal of Cancer
Weinstein, I. B. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,728
A novel cyclin encoded by a bcl1-linked candidate oncogene
Motokura, T., Bloom, T., Kim, H. G., Jüppner., H., Ruderman, J. V., Kronenberg, H. M., & Arnold, A. (1991) · Nature · doi:10.1038/350512a0 · Cited by 1,265
Self-citationColony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
Cyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
Xiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 965
Self-citationSpecific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions
Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., & Pestell, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23589 · Cited by 803
Self-citationSinn, E., Muller, W., Pattengale, P., Tepler, I., Wallace, R., & Leder, P. (1987) · Cell · doi:10.1016/0092-8674(87)90449-1 · Cited by 792
Gillett, C., Fantl, V., Smith, D., Fisher, C., Bartek, J. J., Dickson, C., Barnes, D. M., & Peters, G. (1994) · PubMed · Cited by 750
CDK-Independent Activation of Estrogen Receptor by Cyclin D1
Zwijsen, R. M. L., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., & Michalides, R. J. A. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81879-6 · Cited by 720
Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.
Fantl, V, Stamp, G., Andrews, A., Rosewell, I., & Dickson, C. (1995) · Genes & Development · doi:10.1101/gad.9.19.2364 · Cited by 691
Xiong, Y., Connolly, T., Futcher, B., & Beach, D. (1991) · Cell · doi:10.1016/0092-8674(91)90100-d · Cited by 685
Expression and amplification of cyclin genes in human breast cancer.
Buckley, M. F., Sweeney, K. J. E., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., DeFazio, A., Watts, C. K. W., Musgrove, E. A., & Sutherland, R. L. (1993) · PubMed · Cited by 667
Cyclin E and Survival in Patients with Breast Cancer
Keyomarsi, K., Tucker, S. L., Buchholz, T. A., Callister, M., Ding, Y., Hortobagyi, G. N., Bedrosian, I., Knickerbocker, C., Toyofuku, W., Lowe, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021153 · Cited by 557
Alt, J. R., Cleveland, J. L., Hannink, M., & Diehl, J. A. (2000) · Genes & Development · doi:10.1101/gad.854900 · Cited by 535
Cyclin D1 protein expression and function in human breast cancer
Bartkova, J., Lukas, J., Müller, H., Lützhøt, D., Strauss, M., & Bartek, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570311 · Cited by 509
Function of a human cyclin gene as an oncogene.
Hinds, P. W., Dowdy, S. F., Eaton, E. N., Arnold, A., & Weinberg, R. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.709 · Cited by 454
Self-citationPRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.
Rosenberg, C. L., Wong, E., Petty, E. M., Bale, A. E., Tsujimoto, Y., Harris, N. L., & Arnold, A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9638 · Cited by 432
Self-citationLinking cyclins to transcriptional control
Coqueret, O. (2002) · Gene · doi:10.1016/s0378-1119(02)01055-7 · Cited by 431
EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian Cancer
Hughes-Davies, L., Huntsman, D., Ruas, M., Fuks, F., Bye, J., Chin, S.-F., Milner, J., Brown, L. A., Hsu, F., Gilks, B., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00930-9 · Cited by 421
A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer
Lamb, J., Ramaswamy, S., Ford, H. L., Contreras, B., Martinez, R. V., Kittrell, F. S., Zahnow, C. A., Patterson, N., Golub, T. R., & Ewen, M. E. (2003) · Cell · doi:10.1016/s0092-8674(03)00570-1 · Cited by 416
Alternate splicing produces a novel cyclin D1 transcript.
Betticher, D., Thatcher, N., Altermatt, H. J., Hoban, P. R., Ryder, W. D. J., & Heighway, J. (1995) · PubMed · Cited by 399
Cyclin D1 Stimulation of Estrogen Receptor Transcriptional Activity Independent of cdk4†
Neuman, E., Ladha, M. H., Lin, N., Upton, T. M., Miller, S. J., DiRenzo, J., Pestell, R. G., Hinds, P. W., Dowdy, S. F., Brown, M., et al. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5338 · Cited by 392
Cyclin D1 is an essential mediator of apoptotic neuronal cell death.
Kranenburg, O., van der Eb, A. J., & Zantema, A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00332.x · Cited by 379
Lammie, G. A., Fantl, V., Smith, R., Schuuring, E., Brookes, S., Michalides, R. J. A. M., Dickson, C., Arnold, A., & Peters, G. B. (1991) · PubMed · Cited by 371
Self-citationAltered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.
Jiang, W., Zhang, Y. J., Kahn, S. M., Hollstein, M. C., Santella, R. M., Lu, S. H., Harris, C. C., Montesano, R., & Weinstein, I. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9026 · Cited by 360
Arnold, A., Kim, H. G., Gaz, R. D., Eddy, R. L., Fukushima, Y., Byers, M. G., Shows, T. B., & Kronenberg, H. M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114114 · Cited by 353
Self-citationAltucci, L., Addeo, R., Cicatiello, L., Dauvois, S., Parker, M., Truss, M., Beato, M., Sica, V., Bresciani, F., & Weisz, A. (1996) · PubMed · Cited by 343
Rescue of Cyclin D1 Deficiency by Knockin Cyclin E
Geng, Y., Whoriskey, W., Park, M. Y., Bronson, R. T., Medema, R. H., Li, T., Weinberg, R. A., & Sicinski, P. (1999) · Cell · doi:10.1016/s0092-8674(00)80788-6 · Cited by 336
Weinstat-Saslow, D., Merino, M. J., Manrow, R. E., Lawrence, J. A., Bluth, R. F., Wittenbel, K. D., Simpson, J. F., Page, D. L., & Steeg, P. S. (1995) · Nature Medicine · doi:10.1038/nm1295-1257 · Cited by 335
Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1
Zwijsen, R. M. L., Buckle, R. S., Hijmans, E. M., Loomans, C. J. M., & Bernards, R. (1998) · Genes & Development · doi:10.1101/gad.12.22.3488 · Cited by 305
Musgrove, E. A., Hamilton, J. A., Lee, C. S., Sweeney, K. J., Watts, C. K., & Sutherland, R. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3577 · Cited by 297
Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog
Tomlinson, I., & Bodmer, W. (1999) · Nature Medicine · doi:10.1038/4687 · Cited by 296
Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts
Pagano, M., Theodoras, A. M., Tam, S. W., & Draetta, G. F. (1994) · Genes & Development · doi:10.1101/gad.8.14.1627 · Cited by 294
Cyclin D1, EMS1 and 11q13 Amplification in Breast Cancer
Ormandy, C. J., Musgrove, E. A., Hui, R., Daly, R. J., & Sutherland, R. L. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1023033708204 · Cited by 270
Schuuring, E. (1995) · Gene · doi:10.1016/0378-1119(94)00562-7 · Cited by 268
Estrogen-Dependent Cyclin E-cdk2 Activation through p21 Redistribution
Planas-Silva, M. D., & Weinberg, R. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4059 · Cited by 267
Prognostic molecular markers in early breast cancer
Esteva, F. J., & Hortobagyi, G. N. (2004) · Breast Cancer Research · doi:10.1186/bcr777 · Cited by 247
Induction of Mammary Gland Hyperplasia and Carcinomas in Transgenic Mice Expressing Human Cyclin E
Bortner, D. M., & Rosenberg, M. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.453 · Cited by 245
Barnes, D. M., & Gillett, C. E. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006103831990 · Cited by 243
An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.
Lu, F., Gladden, A. B., & Diehl, J. A. (2003) · PubMed · Cited by 239
Courjal, F., Cuny, M., Simony-Lafontaine, J., Louason, G., Speiser, P., Zeillinger, R., Rodríguez, C., & Theillet, C. G. (1997) · PubMed · Cited by 238
PRAD-1 (CCND1)/Cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma
Callender, T., El‐Naggar, A. K., Lee, M. S., Frankenthaler, R. A., Luna, M. A., & Batsakis, J. G. (1994) · Cancer · doi:10.1002/1097-0142(19940701)74:1<152::aid-cncr2820740124>3.0.co;2-k · Cited by 235
Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells.
Arber, N., Doki, Y., Han, E. K.-H., Sgambato, A., Zhou, P., Kim, N. H., Delohery, T. M., Klein, M. G., Holt, P. R., & Weinstein, I. B. (1997) · PubMed · Cited by 226
Solomon, D. A., Wang, Y., Fox, S. R., Lambeck, T. C., Giesting, S., Lan, Z., Senderowicz, A. M., & Knudsen, E. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303969200 · Cited by 218
HER-2-targeted therapy: lessons learned and future directions.
Nahta, R., & Esteva, F. J. (2003) · PubMed · Cited by 214
Cyclin D1 Repression of Peroxisome Proliferator-Activated Receptor γ Expression and Transactivation
Wang, C., Pattabiraman, N., Zhou, J. N., Fu, M., Sakamaki, T., Albanese, C., Li, Z., Wu, K., Hulit, J., Neumeister, P., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6159-6173.2003 · Cited by 196
Albanese, C., D'Amico, M., Reutens, A. T., Fu, M., Watanabe, G., Lee, R. J., Kitsis, R. N., Henglein, B., Avantaggiati, M., Somasundaram, K., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34186 · Cited by 190
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
McMahon, C., Suthiphongchai, T., DiRenzo, J., & Ewen, M. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5382 · Cited by 178
Prevalence of somatic alterations in the colorectal cancer cell genome
Wang, T.-L., Rago, C., Silliman, N., Ptak, J., Markowitz, S., Willson, J. K. V., Parmigiani, G., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261714699 · Cited by 177
Diehl, J. A., & Sherr, C. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7362 · Cited by 173
Inoue, K., & Sherr, C. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1590 · Cited by 168
IKKα Regulates Mitogenic Signaling through Transcriptional Induction of Cyclin D1 via Tcf
Albanese, C., Wu, K., D’Amico, M., Jarrett, C. R., Joyce, D. A., Hughes, J. R., Hulit, J., Sakamaki, T., Fu, M., Ben‐Ze'ev, A., et al. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-06-0101 · Cited by 165
Motokura, T., & Arnold, A. (1993) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870070205 · Cited by 163
Self-citationFrom centrocytic to mantle cell lymphoma: A clinicopathologic and molecular review of 3 decades
Swerdlow, S. H., & Williams, M. E. (2002) · Human Pathology · doi:10.1053/hupa.2002.30221 · Cited by 159
Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast.
Alle, K. M., Henshall, S. M., Field, A. S., & Sutherland, R. L. (1998) · PubMed · Cited by 159
Hosokawa, Y., & Arnold, A. (1998) · Genes Chromosomes and Cancer · Cited by 147
Self-citationCyclin D1: Mechanism and Consequence of Androgen Receptor Co-repressor Activity
Petre, C. E., Wetherill, Y. B., Danielsen, M., & Knudsen, K. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106399200 · Cited by 144
Kornmann, M., Arber, N., & Korc, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1323 · Cited by 142
Tumour-suppressor genes: evolving definitions in the genomic age
Haber, D. A., & Harlow, E. (1997) · Nature Genetics · doi:10.1038/ng0897-320 · Cited by 141
Interaction of D-Type Cyclins with a Novel myb-Like Transcription Factor, DMP1
Hirai, H., & Sherr, C. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6457 · Cited by 131
Zukerberg, L. R., Yang, W. I., Gadd, M. A., Thor, A. D., Koerner, F. C., Schmidt, E. V., & Arnold, A. (1995) · PubMed · Cited by 128
Self-citationCritical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma
Bergsagel, P. L., & Kuehl, W. M. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00052.x · Cited by 127
Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma.
Williams, M. E., Swerdlow, S. H., Rosenberg, C. L., & Arnold, A. (1993) · PubMed · Cited by 127
Self-citationCyclin D1 gene (CCND1) mutations in endometrial cancer
Moreno‐Bueno, G., Rodríguez, S., Sánchez‐Estévez, C., Hardisson, D., Sarrió, D., Prat, J., Cigudosa, J. C., Matías‐Guiu, X., & Palacios, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206868 · Cited by 125
Small molecule modulators of cyclin-dependent kinases for cancer therapy
Senderowicz, A. M. (2000) · Oncogene · doi:10.1038/sj.onc.1204085 · Cited by 124
Steeg, P. S., & Zhou, Q. Y. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006102916060 · Cited by 119
Borg, Å., Sigurdsson, H., Gm, C., Fernö, M., Fuqua, S. A. W., Olsson, H. L., Killander, D., & McGurie, W. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.28 · Cited by 119
Bièche, I., Olivi, M., Noguès, C., Vidaud, M., & Lidereau, R. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600109 · Cited by 112
Overexpression of cyclin D1 enhances gene amplification.
Zhou, P., Jiang, W. B., Weghorst, C. M., & Weinstein, I. B. (1996) · PubMed · Cited by 111
Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas.
Sauter, E. R., Nesbit, M., Litwin, S., Klein–Szanto, A. J., Cheffetz, S., & Herlyn, M. (1999) · PubMed · Cited by 110
Activation of cyclin D1 expression by the ERK5 cascade
Mulloy, R., Salinas, S., Philips, A., & Hipskind, R. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206839 · Cited by 107
Devilee, P., Cleton-Jansen, A., & Cornelisse, C. J. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02416-7 · Cited by 106
Martín‐Fernández, J. M., Balkenende, A., Verschoor, T., Lallemand, F., & Michalides, R. J. A. M. (1999) · PubMed · Cited by 105
Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast.
Oyama, T., Kashiwabara, K., Yoshimoto, K., Arnold, A., & Koerner, F. (1998) · PubMed · Cited by 101
Self-citationA variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene
Komatsu, H., Iida, S., Yamamoto, K., Mikuni, C., Nitta, M., Takahashi, T., Ueda, R., & Seto, M. (1994) · Blood · doi:10.1182/blood.v84.4.1226.1226 · Cited by 100
Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells
Sweeney, K. J. E., Swarbrick, A., Sutherland, R. L., & Musgrove, E. A. (1998) · Oncogene · doi:10.1038/sj.onc.1201814 · Cited by 93
Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development
Lieubeau, B., Heymann, M., Henry, F., Barbieux, I., Méflah, K., & Gr�goire, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990517)81:4<616::aid-ijc18>3.0.co;2-s · Cited by 85
A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line.
Lebwohl, D., Muise‐Helmericks, R. C., Sepp‐Lorenzino, L., Serve, S., Timaul, M. N., Bol, R., Borgen, P. I., & Rosen, N. X. (1994) · PubMed · Cited by 84
Regulation of B-Myb activity by cyclin D1
Horstmann, S., Ferrari, S. M., & Klempnauer, K.-H. (2000) · Oncogene · doi:10.1038/sj.onc.1203302 · Cited by 69
Hosokawa, Y., Gadd, M. A., Smith, A. P., Koerner, F. C., Schmidt, E. V., & Arnold, A. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)04605-3 · Cited by 67
Self-citationDifferential Expression and Mutation of therasFamily Genes in Human Breast Cancer
Miyakis, S., Sourvinos, G., & Spandidos, D. A. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9527 · Cited by 65
Howe, D. J., & Lynas, C. (2001) · PubMed · Cited by 65
EGF-r gene copy number changes in renal cell carcinoma detected by fluorescencein situ hybridization
Moch, H., Sauter, G., Gasser, T. C., Bubendorf, L., Richter, J., Presti, J. C., Waldman, F. M., & Mihatsch, M. J. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199804)184:4<396::aid-path1259>3.0.co;2-g · Cited by 64
Bowe, D. B., Kenney, N. J., Adereth, Y., & Maroulakou, I. G. (2002) · Oncogene · doi:10.1038/sj.onc.1205025 · Cited by 61
CDK-independent activities of D type cyclins
Bernards, R. (1999) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00024-4 · Cited by 55
The 870G>A Polymorphism of the Cyclin D1 Gene is not Associated with Breast Cancer
Krippl, P., Langsenlehner, U., Renner, W., Yazdani‐Biuki, B., Wolf, G. L., Wascher, T. C., Paulweber, B., Weitzer, W., Leithner, A., & Samonigg, H. (2003) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000004372.20461.33 · Cited by 47
Lung, J. C., Chu, J., Yu, J., Yue, C., Lo, Y., Shen, C., & Wu, C. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10072 · Cited by 46
Functional domains in cyclin D1: pRb-kinase activity is not essential for transformation
Zwicker, J., Brüsselbach, S., Jooss, K. U., Sewing, A., Behn, M., Lucibello, F. C., & Müller, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202286 · Cited by 43
Hsiang, C., & Straus, D. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205293 · Cited by 27
Inhibition of estrogen-dependent breast cell responses with phenylacetate
Sawatsri, S., Samid, D., Malkapuram, S., & Sidell, N. (2001) · International Journal of Cancer · doi:10.1002/ijc.1399 · Cited by 23
Imatinib Mesylate in the Treatment of Chronic Myelogenous Leukemia
Borthakur, G. M., & Cortes, J. E. (2004) · International Journal of Hematology · doi:10.1532/ijh97.04054 · Cited by 19
Cited by
Finn, R. S., Dering, J., Conklin, D., Kalous, O., Cohen, D. J., Desai, A. J., Ginther, C., Atefi, M., Chen, I., Fowst, C., et al. (2009) · Breast Cancer Research · doi:10.1186/bcr2419 · Cited by 1,398
Cyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment
Shapiro, G. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7689 · Cited by 1,036
Cyclin D1, cancer progression, and opportunities in cancer treatment
Qie, S., & Diehl, J. A. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1475-3 · Cited by 657
Ding, L., Cao, J., Lin, W., Chen, H., Xiong, X., Ao, H., Yu, M., Lin, J., & Cui, Q. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061960 · Cited by 618
Metadata
- Authors
- Arnold, A., & Papanikolaou, A.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-06-20
- Volume
- 23
- Issue
- 18
- Pages
- 4215-4224
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2111369086
- Cited by
- 411
- References
- 97
- FWCI
- 7.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.